Rife and R.I.F.E. machines defined - Research into the Resonance Therapy and Rife Microscope, Rife Research - Europe

Go to content

Main menu:

Rife and R.I.F.E. machines defined

Research > Freqencies
Widespread confusion and misinformation regarding so-called "Rife machines" necessitates that we clearly define and distinguish two separate classes of devices. The goal is to provide a common framework of clear and accurate information for people to use in making decisions when choosing and or purchasing a device, and also when communicating with and reporting results to others. This article is an edited version on the description on the Rife Forum by Jason Ringas of Rife Research, Canada.

What is a Rife machine?

A Rife machine can be summarized very simply as an electronic antibiotic. Specific frequencies are determined and targeted toward specific microorganisms, resulting in their devitalization. The germicidal frequencies, called Mortal Oscillatory Rates (MORs) are determined through a very painstaking process of laboratory research. Cultures of a particular microorganism are developed and used for testing frequencies until a frequency is found that is lethal to the organism. When the frequency is thoroughly confirmed "in vitro" on the cultures of microorganisms, it can then be tested on animals or humans that are infected with the same organism.

What distinguishes a Rife machine from other types of frequency devices is not any particular type of technology or hardware, such as vacuum tubes vs. solid state, or analog vs. digital, but rather the methodology used to test and confirm it.

Clinical therapeutic efficacy is not a determining factor in whether a particular device qualifies to be called a "Rife machine". At the time of this writing, there are no commercially available devices that qualify to be called Rife machines, for the simple reason that none of them have been demonstrated according to the standards and methodology established by Royal Rife.

What are R.I.F.E. machines?

The acronym R.I.F.E. was first coined by Dr. James Bare, D.C., and stands for Resonance Initiated Field Effect, or Resonance Initiated Frequency Effect. This class of devices and the effects they produce is much wider and varied than the narrowly defined Rife machine, and there is no real or legitimate connection to the work of Royal Rife. This has caused the present state of confusion regarding the two classes of devices.

R.I.F.E. machines include all of the currently available devices that use variable frequencies, usually in the audio (20-20,000 Hz) spectrum. Examples include the so-called "Doug device", which uses a coil to apply the variable audio frequencies, various types of "pad" machines, which use some type of electrodes to apply the frequencies directly to the body, and the two main types of plasma tube devices, which use either high voltage audio, or a modulated radio frequency carrier wave to apply the frequencies through the plasma tube and without any physical contact. As a general statement, all of these devices "work", in the sense that they are therapeutically effective and have provided many people relief from a very wide assortment of ailments. They don't necessarily work for everything and everyone, but they work for many things and many people.

The apparent primary mechanism for the clinical effects observed with R.I.F.E. machines is a physiological one as opposed to a direct germicidal effect of the Rife machine. The applied frequencies affect the body in a manner that helps it to recover from the condition. It is also possible that this class of devices, or at least some examples within it, produce direct germicidal effects similar to the Rife machine, but the critical difference is that it has not been demonstrated according to Rife's methodology. This is the fundamental factor that distinguishes these two classes of devices, the methodology used to demonstrate them. R.I.F.E. machines can be demonstrated by direct clinical trials, or even by personal empirical testing, which is how most people use these devices. If an individual with a particular condition is relieved or healed of that condition by the use of a frequency device, that's all that matters to them. It should also be noted that R.I.F.E. machines are used for many conditions that have nothing to do with microorganisms, making them generally more versatile than the specific purpose of the Rife machine. The Rife machine also has non germicidal effects, such as in treating the chemical reaction that causes cataracts, but the primary purpose and intent is to devitalize microorganisms.

It is hoped that the above has clarified at least most of the confusion and misinformation regarding the two different classes of frequency devices called Rife and R.I.F.E. machines. Rife's work was about a specific methodology.

Rife's methodology

Rife's methodology was about testing and confirming frequencies on microorganisms "in vitro", meaning, in the laboratory. Only after a frequency was laboratory tested and confirmed was it then tested "in vivo", or in a body. The principle of Rife's methodology is very simple, but the execution is not so simple. It sometimes took Rife months, working 16-20 hours a day, to find a single frequency. Modern technology could make this much faster and easier, but there's no getting around the need for objective testing.

In contrast to Rife's methodology, the modern machines are for the most part tested and used empirically. If a person (or animal) with a certain disease or condition improves with a frequency or frequencies, then those are recorded for that condition. You'll notice that with the modern machines, there are often many frequencies for one condition, and also that there are many conditions treated that are not caused by microorganisms. Frequencies are also sometimes determined through muscle testing, dowsing, or other similar methods.

As you can see from this brief summary, there is a fundamental difference between Rife's methodology and the paradigm of the modern machines.

© Copyright: 1999 - 2017, Rife Research, Europe.
© 99-2017, Rife Research, Europe
Back to content | Back to main menu